News|Articles|June 2, 2016

Pharmapack Europe Launches Start-up Hub

The Start-up Hub is designed to give start-up companies the opportunity to network at Pharmapack.

On May 31, 2016 Pharmapack Europe announced the launch of its Start-up Hub, a new addition to the 2017 event at the Paris Expo Porte de Versailles from February 1-2, 2017. According to Pharmapack, the Start-up Hub is a platform designed to give young pharmaceutical firms the ability to network at the conference for an affordable price. Companies at the Start-up Hub will have the opportunity to showcase ideas, meet potential customers, partners and investors, and forge new relationships.

According to Pharmapack, there are only ten spots available for companies in the Start-up Hub. Exhibitors will be selected by Pharmapack’s advisory board of industry experts. The board will fill available spots based on the uniqueness, market prospects, patient impact, and savings potential of each company’s innovations, Pharmapack said in a press announcement. Firms pursuing all types of pharma and biopharma packaging innovation are encouraged to apply. Entry closes on July 28, 2016 and recipients will be announced in early September.

Source: Pharmapack Europe


Related to this article

Trophy and confetti on light background, top view with space for text. Victory concept | Image Credit: ©New Africa -stock.adobe.com
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.